BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/13/2014 7:02:00 PM | Browse: 1074 | Download: 1525
 |
Received |
|
2014-05-30 08:47 |
 |
Peer-Review Started |
|
2014-05-30 19:57 |
 |
To Make the First Decision |
|
2014-07-10 17:22 |
 |
Return for Revision |
|
2014-07-11 16:15 |
 |
Revised |
|
2014-07-16 11:18 |
 |
Second Decision |
|
2014-09-24 16:07 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-09-24 16:20 |
 |
Articles in Press |
|
2014-09-24 16:20 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-10-14 16:26 |
 |
Publish the Manuscript Online |
|
2014-12-13 19:01 |
Category |
Medicine, Research & Experimental |
Manuscript Type |
Review |
Article Title |
Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives
|
Manuscript Source |
Invited Manuscript |
All Author List |
Alexander E Berezin |
Funding Agency and Grant Number |
|
Corresponding Author |
Alexander E Berezin, MD, PhD, Professor, Chief of Cardiology Unit, Department of Internal Medicine, State Medical University, 26, Mayakovsky av., 69035 Zaporozhye, Ukraine. dr_berezin@mail.ru
|
Key Words |
Diabetes mellitus; Regenerative medicine; Stem cells; Cellular reprogramming; Transplantation |
Core Tip |
Modern approaches to stem cell therapy are discussed a promising component of treatment program in diabetes mellitus. It is important to emphasize that the new technology that is associated with reprogramming of stem cells has a couple of disputes in accordance with the ethical considerations and practical issues. However, the extremely high cost of novel methods toward preventing immune rejection of graft tissue and the high risk of oncogenesis retain their value as major constraints to the implementation into routine clinical practice. The purpose of the review was to summarize and analyze data for existing knowledge and prospects for future researches in the field of regenerative therapy in patients with diabetes mellitus.
|
Publish Date |
2014-12-13 19:01 |
Citation |
Berezin AE. Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives. World J Diabetes 2014; 5(6): 777-786 |
URL |
http://www.wjgnet.com/1948-9358/full/v5/i6/777.htm |
DOI |
http://dx.doi.org/10.4239/wjd.v5.i6.777 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345